×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
PFE – pfizer, inc. (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
PFE
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/20
02:05 pm
pfe
U.S. FDA Approves Pfizer's BRAFTOVI® Combination Regimen as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal Cancer [Yahoo! Finance]
Low
Report
U.S. FDA Approves Pfizer's BRAFTOVI® Combination Regimen as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal Cancer [Yahoo! Finance]
12/20
02:03 pm
pfe
U.S. FDA Approves Pfizer’s BRAFTOVI® Combination Regimen as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal Cancer
Low
Report
U.S. FDA Approves Pfizer’s BRAFTOVI® Combination Regimen as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal Cancer
12/20
07:27 am
pfe
Is Pfizer (PFE) a Cheap NYSE Stock to Invest in Now? [Yahoo! Finance]
Medium
Report
Is Pfizer (PFE) a Cheap NYSE Stock to Invest in Now? [Yahoo! Finance]
12/19
07:11 pm
pfe
Why Pfizer (PFE) Dipped More Than Broader Market Today [Yahoo! Finance]
Low
Report
Why Pfizer (PFE) Dipped More Than Broader Market Today [Yahoo! Finance]
12/19
11:30 am
pfe
GoComet's Odyssey Singapore 2024 Highlights: When Supply Chain Giants Meet
Low
Report
GoComet's Odyssey Singapore 2024 Highlights: When Supply Chain Giants Meet
12/19
10:00 am
pfe
Pfizer Invites Public to View and Listen to Webcast of February 4 Conference Call with Analysts
Low
Report
Pfizer Invites Public to View and Listen to Webcast of February 4 Conference Call with Analysts
12/19
08:15 am
pfe
Anokion Announces the Early Completion of Enrollment in the ACeD-it Phase 2 and the SynCeD Phase 2a Trials of KAN-101 for the Treatment of Celiac Disease [Yahoo! Finance]
Low
Report
Anokion Announces the Early Completion of Enrollment in the ACeD-it Phase 2 and the SynCeD Phase 2a Trials of KAN-101 for the Treatment of Celiac Disease [Yahoo! Finance]
12/19
06:16 am
pfe
Roam For the Holidays: Grindr Offers Free Access to Their Popular Travel Feature [Yahoo! Finance]
Low
Report
Roam For the Holidays: Grindr Offers Free Access to Their Popular Travel Feature [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/17
05:20 pm
pfe
Form 4 PFIZER INC For: Dec 13 Filed by: BOURLA ALBERT
Low
Report
Form 4 PFIZER INC For: Dec 13 Filed by: BOURLA ALBERT
12/17
08:05 am
pfe
Form 4 PFIZER INC For: Dec 13 Filed by: JOHNSON RADY A
Low
Report
Form 4 PFIZER INC For: Dec 13 Filed by: JOHNSON RADY A
12/17
07:47 am
pfe
Form 8-K PFIZER INC For: Dec 17
Low
Report
Form 8-K PFIZER INC For: Dec 17
12/2
04:18 pm
pfe
Form 4 PFIZER INC For: Nov 29 Filed by: BOURLA ALBERT
Low
Report
Form 4 PFIZER INC For: Nov 29 Filed by: BOURLA ALBERT
12/2
04:18 pm
pfe
Form 4 PFIZER INC For: Nov 29 Filed by: JOHNSON RADY A
Low
Report
Form 4 PFIZER INC For: Nov 29 Filed by: JOHNSON RADY A
11/18
04:31 pm
pfe
Form 4 PFIZER INC For: Nov 15 Filed by: BOURLA ALBERT
Low
Report
Form 4 PFIZER INC For: Nov 15 Filed by: BOURLA ALBERT
11/18
04:30 pm
pfe
Form 4 PFIZER INC For: Nov 15 Filed by: JOHNSON RADY A
Low
Report
Form 4 PFIZER INC For: Nov 15 Filed by: JOHNSON RADY A
11/4
04:08 pm
pfe
Form 10-Q PFIZER INC For: Sep 29
Low
Report
Form 10-Q PFIZER INC For: Sep 29
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/12
How to invest when the coronavirus pandemic and Trump send the Dow crashing: experts [Yahoo! Finance News]
10.1%
3/26 Mylan and Pfizer Provide Update Regarding Proposed Combination of Mylan and Upjohn 7.6%
3/16 Form 4 PFIZER INC For: Mar 13 Filed by: YOUNG JOHN D 6.3%
3/27 Form 8-K PFIZER INC For: Mar 25 5.8%
3/4 Europe 'panicking' over India's pharmaceutical export curbs - industry group [Reuters] 5.3%
2/28 Form 4 PFIZER INC For: Feb 26 Filed by: LANKLER DOUGLAS M 4.4%
4/1 Medical Professionals Across Merck & Co., Inc., Pfizer Inc., and Eli Lilly and Company Activate to Support Health Systems, First Responders and Patients Amid COVID-19 Pandemic 3.5%
3/9 Form 3 PFIZER INC For: Mar 01 Filed by: DAMICO JENNIFER B. 3.2%
3/17 Coronavirus Spreads To All 50 States As 1st Case Reported In West Virginia; NYPD Officer Tests Positive [zero hedge] 3.1%
4/9 Pfizer says early studies of potential coronavirus treatment show promise [Reuters] 2.8%
3/26 Mylan and Pfizer Provide Update Regarding Proposed Combination of Mylan and Upjohn 7.6%
3/16 Form 4 PFIZER INC For: Mar 13 Filed by: YOUNG JOHN D 6.3%
3/27 Form 8-K PFIZER INC For: Mar 25 5.8%
3/4 Europe 'panicking' over India's pharmaceutical export curbs - industry group [Reuters] 5.3%
2/28 Form 4 PFIZER INC For: Feb 26 Filed by: LANKLER DOUGLAS M 4.4%
4/1 Medical Professionals Across Merck & Co., Inc., Pfizer Inc., and Eli Lilly and Company Activate to Support Health Systems, First Responders and Patients Amid COVID-19 Pandemic 3.5%
3/9 Form 3 PFIZER INC For: Mar 01 Filed by: DAMICO JENNIFER B. 3.2%
3/17 Coronavirus Spreads To All 50 States As 1st Case Reported In West Virginia; NYPD Officer Tests Positive [zero hedge] 3.1%
4/9 Pfizer says early studies of potential coronavirus treatment show promise [Reuters] 2.8%
TOP News Decliners
8/8
Form 10-Q PFIZER INC For: Jun 30
-15.1%
3/13 A 5-point plan for pharmaceutical companies [MSNBC.com] -8.1%
7/29 How Big Is Pfizer's Generic Drugs Business That It Plans To Merge With Mylan? [Forbes] -6.5%
3/10 Zentalis Pharmaceuticals Seeks Development Funding From IPO [Seeking Alpha] -6.5%
3/20 ViiV Healthcare Announces First Global Regulatory Approval of CABENUVA; the First Complete, Long-acting, Regimen for the Treatment of HIV -6.4%
3/18 Pfizer Announces Top-Line Results from Phase 3 Study of 20-Valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naïve Adults Aged 18 Years or Older -6.2%
7/29 M&A deals make major headlines [Seeking Alpha] -5.8%
1/28 Q4/2019 12/31/2019 EPS 0.550 ZacksConsensus 0.570 ActVsEst (0.020) - Miss -5.5%
3/6 Iran Hawks Pressuring White House To Halt 'Humanitarian' Medicine To Iran Amid Outbreak [zero hedge] -4.8%
4/28 US STOCKS-Wall St set to jump as 3M, Pfizer earnings impress [Reuters] -3.4%
3/13 A 5-point plan for pharmaceutical companies [MSNBC.com] -8.1%
7/29 How Big Is Pfizer's Generic Drugs Business That It Plans To Merge With Mylan? [Forbes] -6.5%
3/10 Zentalis Pharmaceuticals Seeks Development Funding From IPO [Seeking Alpha] -6.5%
3/20 ViiV Healthcare Announces First Global Regulatory Approval of CABENUVA; the First Complete, Long-acting, Regimen for the Treatment of HIV -6.4%
3/18 Pfizer Announces Top-Line Results from Phase 3 Study of 20-Valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naïve Adults Aged 18 Years or Older -6.2%
7/29 M&A deals make major headlines [Seeking Alpha] -5.8%
1/28 Q4/2019 12/31/2019 EPS 0.550 ZacksConsensus 0.570 ActVsEst (0.020) - Miss -5.5%
3/6 Iran Hawks Pressuring White House To Halt 'Humanitarian' Medicine To Iran Amid Outbreak [zero hedge] -4.8%
4/28 US STOCKS-Wall St set to jump as 3M, Pfizer earnings impress [Reuters] -3.4%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: